Search

Steven J Mottola

Examiner (ID: 17760, Phone: (571)272-1766 , Office: P/2842 )

Most Active Art Unit
2817
Art Unit(s)
2515, 2842, 2843, 2817, 2502, 2607, 3621
Total Applications
3603
Issued Applications
3334
Pending Applications
99
Abandoned Applications
170
Applications
StatisticsSubscription-Only

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 5912957 [patent_doc_number] => 20060128019 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-15 [patent_title] => 'Process for producing virus vector containing membrane protein having sialic acid-binding in envelope with the use of gram-positive bacterium origin nueraminidase' [patent_app_type] => utility [patent_app_number] => 10/526650 [patent_app_country] => US [patent_app_date] => 2003-09-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 18678 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0128/20060128019.pdf [firstpage_image] =>[orig_patent_app_number] => 10526650 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/526650 		Process for producing virus vector containing membrane protein having sialic acid-binding in envelope with the use of gram-positive bacterium origin nueraminidase Sep 3, 2003 Abandoned
Array ( [id] => 7303244 [patent_doc_number] => 20040115221 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-17 [patent_title] => 'Intracellular delivery vehicles' [patent_app_type] => new [patent_app_number] => 10/627452 [patent_app_country] => US [patent_app_date] => 2003-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 9707 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0115/20040115221.pdf [firstpage_image] =>[orig_patent_app_number] => 10627452 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/627452 		Intracellular delivery vehicles Jul 24, 2003 Abandoned
Array ( [id] => 6938532 [patent_doc_number] => 20050112095 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-26 [patent_title] => 'Internal ribosome entry sites for recombinant protein expression' [patent_app_type] => utility [patent_app_number] => 10/614283 [patent_app_country] => US [patent_app_date] => 2003-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 7987 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0112/20050112095.pdf [firstpage_image] =>[orig_patent_app_number] => 10614283 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/614283 		Internal ribosome entry sites for recombinant protein expression Jul 7, 2003 Abandoned
Array ( [id] => 5649666 [patent_doc_number] => 20060135401 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-22 [patent_title] => 'Novel method of selecting immunosuppressant having little thrombocytopenic effect' [patent_app_type] => utility [patent_app_number] => 10/519678 [patent_app_country] => US [patent_app_date] => 2003-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 14194 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0135/20060135401.pdf [firstpage_image] =>[orig_patent_app_number] => 10519678 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/519678 		Novel method of selecting immunosuppressant having little thrombocytopenic effect Jul 6, 2003 Abandoned
Array ( [id] => 6258623 [patent_doc_number] => 20020187128 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-12 [patent_title] => 'Novel replication deficient adenovirus vectors and methods for making and using them' [patent_app_type] => new [patent_app_number] => 10/135895 [patent_app_country] => US [patent_app_date] => 2002-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 21019 [patent_no_of_claims] => 62 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0187/20020187128.pdf [firstpage_image] =>[orig_patent_app_number] => 10135895 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/135895 		Novel replication deficient adenovirus vectors and methods for making and using them Apr 28, 2002 Abandoned
Array ( [id] => 6468825 [patent_doc_number] => 20020151069 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-17 [patent_title] => 'Mosaic adenoviral vectors' [patent_app_type] => new [patent_app_number] => 10/124796 [patent_app_country] => US [patent_app_date] => 2002-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4161 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0151/20020151069.pdf [firstpage_image] =>[orig_patent_app_number] => 10124796 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/124796 		Mosaic adenoviral vectors Apr 16, 2002 Abandoned
09/647965 Highly active forms of interferon regulatory factor proteins May 23, 2001 Abandoned
Array ( [id] => 5656482 [patent_doc_number] => 20060142218 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-29 [patent_title] => 'Method of controlling telomere length' [patent_app_type] => utility [patent_app_number] => 10/204067 [patent_app_country] => US [patent_app_date] => 2001-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6442 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20060142218.pdf [firstpage_image] =>[orig_patent_app_number] => 10204067 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/204067 		Method of controlling telomere length Feb 13, 2001 Abandoned
Array ( [id] => 418684 [patent_doc_number] => 07276356 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2007-10-02 [patent_title] => 'Recombinant negative strand RNA virus expression systems and vaccines' [patent_app_type] => utility [patent_app_number] => 09/724427 [patent_app_country] => US [patent_app_date] => 2000-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 42 [patent_no_of_words] => 31134 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/276/07276356.pdf [firstpage_image] =>[orig_patent_app_number] => 09724427 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/724427 		Recombinant negative strand RNA virus expression systems and vaccines Nov 27, 2000 Issued
Array ( [id] => 648664 [patent_doc_number] => 07115257 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-10-03 [patent_title] => 'ARPE-19 as a platform cell line for encapsulated cell-based delivery' [patent_app_type] => utility [patent_app_number] => 09/958040 [patent_app_country] => US [patent_app_date] => 2000-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 11884 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/115/07115257.pdf [firstpage_image] =>[orig_patent_app_number] => 09958040 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/958040 		ARPE-19 as a platform cell line for encapsulated cell-based delivery Apr 5, 2000 Issued
Array ( [id] => 6079856 [patent_doc_number] => 20020081280 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-06-27 [patent_title] => 'ADENOVIRUS VECTOR CONTAINING A HETEROLOGOUS PEPTIDE EPITOPE IN THE HI LOOP OF THE FIBER KNOB' [patent_app_type] => new [patent_app_number] => 09/245603 [patent_app_country] => US [patent_app_date] => 1999-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 23301 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0081/20020081280.pdf [firstpage_image] =>[orig_patent_app_number] => 09245603 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/245603 		Adenovirus vector containing a heterologous peptide epitope in the hi loop of the fiber knob Feb 4, 1999 Issued
Menu